3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
11
Dermatologic
4
Thoracic
3
Gynecologic
2
Sarcoma
1
Lymphoid
1
Head & Neck
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Sarcoma
19
Neoplasms
7
Osteosarcoma
5
Gastrointestinal Stromal Tumors
4
Neuroblastoma
3
Melanoma
3
Uterine Cervical Neoplasms
2
Testicular Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Glioma
2
Esophageal Neoplasms
2
Desmoid Tumors
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Somatostatinoma
1
Skin Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplastic Cells, Circulating
1
Interventions
Filgrastim
10
Ifosfamide
6
Carboplatin
5
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Doxorubicin
4
Cyclophosphamide
4
pembrolizumab
3
Thiotepa
3
Temozolomide
3
Etoposide
3
Busulfan
3
sargramostim
2
ixabepilone
2
fludarabine phosphate
2
etoposide phosphate
2
belinostat
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Paclitaxel
2
Mycophenolic Acid
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Bortezomib
2
Antilymphocyte Serum
2
Amifostine
2
tremelimumab
1
seribantumab
1
poly ICLC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Blood Specimen Collection
×
Sarcoma
×
Clear all
NCT01528774
2017-07-26
CTC
Comprehensive Cancer Centers of Nevada
Completed
150 enrolled